Quantinno Capital Management LP Acquires 23,913 Shares of Acadia Healthcare Company, Inc. $ACHC

Quantinno Capital Management LP grew its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 25.5% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 117,676 shares of the company’s stock after acquiring an additional 23,913 shares during the quarter. Quantinno Capital Management LP’s holdings in Acadia Healthcare were worth $2,752,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. EverSource Wealth Advisors LLC grew its holdings in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the period. Wells Fargo & Company MN boosted its position in shares of Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after purchasing an additional 1,510 shares in the last quarter. Bayforest Capital Ltd purchased a new stake in Acadia Healthcare in the fourth quarter worth $52,000. Caitong International Asset Management Co. Ltd raised its holdings in Acadia Healthcare by 4,264.8% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock worth $76,000 after purchasing an additional 5,203 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in Acadia Healthcare by 857.8% during the first quarter. Parallel Advisors LLC now owns 6,858 shares of the company’s stock valued at $160,000 after buying an additional 6,142 shares during the period.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target on the stock in a report on Monday, May 4th. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Finally, Guggenheim increased their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $31.53 on Monday. The company’s fifty day simple moving average is $29.01 and its two-hundred day simple moving average is $24.50. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The stock has a market cap of $2.94 billion, a P/E ratio of -2.53, a PEG ratio of 10.23 and a beta of 0.64. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. During the same quarter last year, the business posted $0.83 EPS. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Analysts predict that Acadia Healthcare Company, Inc. will post 1.54 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.